• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Canopy Growth's Tweed Receives Valuable Dealers License

Coming after a multiple year process to design, apply and construct the space, it was announced today that Canopy Growth Corp. (OTC:TWMJF) (TSX:CGC) wholly-owned subsidiary Tweed Inc. received a Dealers License for the company's purpose-build area within their production facility in Smiths Falls, Ontario. 

 

1 of 18

 

Until today there were just 17 licensed dealers in Canada. Four licensed dealers previously existed in the Ontario province before the newly licensed Tweed Inc. Some of these licensed dealers, such as Anandia Labs have already made valuable breakthroughs and discoveries, as mentioned below. 

 

New Capabilities for Tweed

 

This new license will expand Tweed's capabilities in terms of research, production and more. According to the release:

 

Licensed activities will occur in a distinct area of the facility focused on strategic projects beyond Tweed's existing operational scope. As a licensed dealer, Tweed will be able to conduct research and possess cannabis and cannabis derivatives in forms that are not currently covered by the Access to Cannabis for Medical Purposes Regulations (ACMPR). It can also begin development of innovative products for future market opportunities, and with necessary approvals undertake the export of non-dried form of cannabis to other jurisdictions.

 

Innovation & Collaboration

 

This new license and new space will push Tweed beyond dried herb cannabis and into exploring even higher margin alternative methods of cannabanoid delivery. According to the release:

 

"Pursuing and achieving this Dealers Licence reinforces Tweed's commitment to more research, both at Tweed and the recently launched Canopy Health Innovations," said Bruce Linton, Chairman and CEO of Canopy Growth. "We have already begun exploring offerings, markets and potential collaborations for the newly licensed space. We look at this area of our business like an incubator where we can foster fresh ideas for the application of cannabinoids that will drive cannabis innovation forward with the goal of improving our offering to Tweed's global customers."

 

22nd Century and Anandia

 

One existing licensed dealer, Anandia Laboratories in Vancouver, has already been collaborating with 22nd Century Group (NYSE:XXII) on high-CBD cannabis strains, low-THC hemp strains and more since October of 2015. The two companies developed and own rights to 4 genes required for cannabinoid production. 

 

In fact the co-founder of Anandia, Jonathan Page Ph.D. co-led the team that sequenced the cannabis genome in the first place. He has been recognized for years as a leader in the space and has worked closely to help XXII develop valuable cannabis and tobacco related intellectual property (IP) rights. 

 

Conclusion

 

For more information and custom stock charts for Canopy Growth Corp. be sure to check out the company's stock profile in our growing Marijuana Stocks Database. For Canopy Growth Corp.'s press release regarding the new license click here

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.